FDA Orange Book

Is there a generic for Ibtrozi?

Ibtrozi contains taletrectinib adipate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Ibtrozi (taletrectinib adipate). The Orange Book shows its last listed patent expires June 3, 2033 and its last listed exclusivity ends June 11, 2032.

Run it in Rivvi

Map Ibtrozi and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Ibtrozi products in the Orange Book

Ibtrozi products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, oralEQ 200MG BASEMarketed (Rx)None0None

NDA 219713, held by NUVATION BIO INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Ibtrozi patents

Patents listed for Ibtrozi
PatentExpiresCoversUse codeNDA
9751887June 3, 2033Drug substance, Drug productU-4207219713
9187489June 3, 2033Drug substance, Drug productU-4207219713

Ibtrozi exclusivity

Exclusivity listed for Ibtrozi
CodeMeaningExpiresNDA
NCENew chemical entityJune 11, 2030219713
ODE-544Orphan drug exclusivityJune 11, 2032219713

Ibtrozi NDC codes

Questions

Is there a generic for Ibtrozi?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Ibtrozi (taletrectinib adipate). The Orange Book shows its last listed patent expires June 3, 2033 and its last listed exclusivity ends June 11, 2032.

What is the generic name for Ibtrozi?

The active ingredient in Ibtrozi is taletrectinib adipate, per the FDA Orange Book.

When does the Ibtrozi patent expire?

The last patent listed for Ibtrozi in the Orange Book expires June 3, 2033. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Ibtrozi and Taletrectinib Adipate

Try it on your own data today.

Free to start. Most teams are using it the same day.